Best Low Price Stocks To Own Right Now

&l;p&g;&l;img class=&q;dam-image bloomberg size-large wp-image-42449358&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/42449358/960×0.jpg?fit=scale&q; data-height=&q;640&q; data-width=&q;960&q;&g; Bloomberg

That&s;s &q;big dividends&q; in the relative sense.

With the U.S. 10-year Treasury rate at 2.7%, then stocks paying more than a 4% dividend yield are of interest. An equity has more risk intrinsically than a government bond — if you&s;re willing to accept that, then you may find the higher yield a more attractive choice.

All of the stocks listed here have low price/earnings ratios. Again, that&s;s in the relative sense. Since the p/e of the Standard &a;amp; Poor&s;s 500 is about 30 and the p/e of the Russell 2000 is 89, I&s;m calling a p/e of less than 15 &q;small.&q;

&l;strong&g;Alliance Bernstein&l;/strong&g; is in the business of managing financial assets. The price/earnings ratio is 10.9 and the dividend yield is 9.05%.

&l;img class=&q;size-full wp-image-3554&q; src=&q;http://blogs-images.forbes.com/johnnavin/files/2018/05/ab-daily-5-29-18.jpg?width=960&q; alt=&q;&q; data-height=&q;928&q; data-width=&q;1240&q;&g; Alliance Bernstein chart

Best Low Price Stocks To Own Right Now: Koss Corporation(KOSS)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Loxo Oncology, Inc. (NASDAQ: LOXO) rose 17.1 percent to $163.30 in pre-market trading as the company disclosed that LOXO-292 Phase 1 trial abstract was selected for 'Best of ASCO'.
    CytomX Therapeutics, Inc. (NASDAQ: CTMX) rose 11.5 percent to $27.15 in pre-market trading after the company announced presentations at the 2018 ASCO Annual Meeting.
    Check-Cap Ltd. (NASDAQ: CHEK) rose 12.3 percent to $5.47 in pre-market trading after reporting narrower-than-expected Q1 loss.
    Flotek Industries, Inc. (NYSE: FTK) shares rose 7.1 percent to $3.62 in the pre-market trading session.
    Baozun Inc. (NASDAQ: BZUN) shares rose 5.8 percent to $47.65 in pre-market trading after reporting Q1 results.
    World Wrestling Entertainment, Inc. (NYSE: WWE) rose 5.5 percent to $46.00 in pre-market trading.
    Williams Partners L.P. (NYSE: WPZ) rose 5.3 percent to $40.50 in pre-market trading after The Williams Companies, Inc. (NYSE: WMB) announced agreement to acquire all public equity of Williams Partners in a $10.5 billion deal.
    Koss Corporation (NASDAQ: KOSS) shares rose 4.6 percent to $2.72 in pre-market trading after surging 12.55 percent on Wednesday.
    Enphase Energy, Inc. (NASDAQ: ENPH) rose 4.5 percent to $5.85 in pre-market trading after gaining 5.66 percent on Wednesday.
    Farmer Bros. Co. (NASDAQ: FARM) rose 4.1 percent to $27 in pre-market trading after climbing 7.90 percent on Wednesday.
    Kosmos Energy Ltd. (NYSE: KOS) rose 4 percent to $7.70 in pre-market trading.

     

  • [By Lisa Levin] Gainers
    Stellar Biotechnologies, Inc. (NASDAQ: SBOT) rose 32 percent to $2.89 in pre-market trading after the company disclosed that it achieved robust viral clearance for its manufacturing process.
    Babcock & Wilcox Enterprises, Inc. (NYSE: BW) rose 17.7 percent to $3.03 in pre-market trading after an amended 13D filing from Steel Partners Holdings shows a raised stake in the company from 6.99 million shares to 29.98 million shares, or a 17.8 percent stake.
    AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) shares rose 12.7 percent to $3.55 in pre-market trading after the company announced the FDA acceptance of NDA for DSUVIA.
    Williams-Sonoma, Inc. (NYSE: WSM) shares rose 11.7 percent to $54.95 in pre-market trading. after the company reported stronger-than-expected results for its first quarter. The company also raised its FY18 earnings and sales guidance.
    Bilibili Inc. (NASDAQ: BILI) shares rose 9.3 percent to $13.59 in pre-market trading after announcing Q1 results.
    Stein Mart, Inc. (NASDAQ: SMRT) rose 8.1 percent to $3.46 in pre-market trading after reporting strong Q1 earnings.
    Universal Corporation (NYSE: UVV) rose 8.1 percent to $52.35 in pre-market trading after reporting fiscal Q4 results.
    Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) rose 8.1 percent to $5.65 in pre-market trading after gaining 6.30 percent on Wednesday.
    CEL-SCI Corporation (NYSE: CVM) rose 6.1 percent to $3.30 in pre-market trading after climbing 9.51 percent on Wednesday.
    TransEnterix, Inc. (NYSE: TRXC) rose 6 percent to $3.10 in pre-market trading after reporting a loan deal for $40 million in term loans with Hercules Capital.
    Stage Stores, Inc. (NYSE: SSI) rose 5.6 percent to $3.40 in pre-market trading following Q1 results.
    Koss Corporation (NASDAQ: KOSS) shares rose 5.2 percent to $2.42 in the pre-market trading session after falling 2.54 percent on Wednesday.

     

Best Low Price Stocks To Own Right Now: ANI Pharmaceuticals, Inc.(ANIP)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Canaccord Genuity set a $82.00 target price on ANI Pharmaceuticals (NASDAQ:ANIP) in a research report released on Tuesday morning. The firm currently has a buy rating on the specialty pharmaceutical company’s stock.

  • [By Max Byerly]

    Mallinckrodt (NYSE: MNK) and ANI Pharmaceuticals Inc Common Stock (NASDAQ:ANIP) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, analyst recommendations, institutional ownership, valuation, earnings and profitability.

Best Low Price Stocks To Own Right Now: WellCare Helath Plans Inc.(WCG)

Advisors’ Opinion:

  • [By Max Byerly]

    WellCare (NYSE:WCG) had its target price boosted by Wells Fargo from $220.00 to $240.00 in a report released on Wednesday morning. Wells Fargo currently has an outperform rating on the stock.

  • [By Stephan Byrd]

    Federated Investors Inc. PA lessened its holdings in WellCare (NYSE:WCG) by 17.0% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 50,260 shares of the company’s stock after selling 10,275 shares during the period. Federated Investors Inc. PA owned about 0.11% of WellCare worth $9,732,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    WellCare (NYSE: WCG) and Trupanion (NASDAQ:TRUP) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, risk, valuation, earnings, institutional ownership, analyst recommendations and profitability.

  • [By Jon C. Ogg]

    WellCare Health Plans Inc. (NYSE: WCG) was reiterated as Overweight and the price target was raised to $275 from $235 at Cantor Fitzgerald.

    Tuesday’stop analyst upgrades and downgrades includedAmazon, Albermarle, Chevron, CVS, PepsiCo, Roku, United Continental, VMware and Zafgen.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on WellCare Health Plans (WCG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    The Manufacturers Life Insurance Company lowered its position in shares of WellCare Health Plans, Inc. (NYSE:WCG) by 3.4% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 71,193 shares of the company’s stock after selling 2,528 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in WellCare Health Plans were worth $13,785,000 as of its most recent filing with the SEC.

Leave a Reply

Your email address will not be published. Required fields are marked *